Last year, Embecta Corp generated 784.10M USD for its biggest-performing segment, Pen Needles. The United States made the largest contribution, accounting for 579.10M USD last year. For the latest quarter, Embecta Corp reported the revenue of 177.50M USD for the period ending 2026-06-30, which came from the top-performing segment, Pen Needles. International contributed the highest revenue, at 150.90M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Pen Needles

Safety

Syringes

Manufacturing Facility

Other

FY2025

Pen Needles

784.10M(72.57%)

Safety

137.80M(12.75%)

Syringes

124.60M(11.53%)

Manufacturing Facility

19.90M(1.84%)

Other

14.00M(1.30%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

579.10M(53.60%)

607.20M(54.06%)

601.40M(53.66%)

600.30M(53.15%)

609.00M(52.27%)

563.00M(51.84%)

570.00M(51.40%)

International

501.30M(46.40%)

515.90M(45.94%)

519.40M(46.34%)

529.20M(46.85%)

556.00M(47.73%)

523.00M(48.16%)

539.00M(48.60%)